|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 4, 309-312, Copyright © 1990 by European Association for Cardio-thoracic Surgery
B Radovancevic, S Poindexter, S Birovljev, V Velebit, HA McAllister, JM Duncan, D Vega, J Lonquist, CM Burnett and OH Frazier
Allograft coronary artery disease (CAD) is the major determinant of
long-term survival following heart transplantation (HTx). In a group of 210
heart transplant recipients, we diagnosed CAD in 54 (27.1%) by coronary
angiography, postmortem examination or examination of the transplanted
heart at the time of retransplantation. Retrospective analysis of potential
risk factors for the development of CAD was performed for both
immunological (rejection pattern, immunosuppressive therapy,
cytomegalovirus [CMV] infection), and nonimmunological (hyperlipidemia,
smoking, hypertension, diabetes mellitus, obesity) risk factors. The total
number of rejection episodes correlated significantly with the occurrence
of CAD (P less than 0.05), showing that patients who experienced two or
more rejection episodes had an incidence of CAD of 40%, as opposed to a 23%
incidence in patients who experienced no rejection. A composite rejection
score derived from multivariate regression analysis of the severity,
frequency, and timing of acute cardiac rejection episodes was found to
correlate with the development of CAD (P less than 0.05). Postoperative
arterial hypertension also correlated significantly with the onset of CAD
(P less than 0.01), with a 92.6% incidence of hypertension in the group
with CAD versus 76.3% in the group without CAD. Smoking after
transplantation correlated significantly with the occurrence of CAD (P less
than 0.05). There was no significant correlation with other analyzed
factors in this group of patients. In this review, the development of CAD
after heart transplantation correlated with treated allograft rejection.
Aggressive treatment of hypertension and cessation of smoking may
contribute to alleviation of this serious complication.
ARTICLES
Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients
Cullen Cardiovascular Surgical Research Laboratory, Texas Heart Institute, Houston.
This article has been cited by other articles:
![]() |
A. Hognestad, K. Endresen, R. Wergeland, O. Stokke, O. Geiran, T. Holm, S. Simonsen, J. K. Kjekshus, and A. K. Andreassen Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients J. Am. Coll. Cardiol., August 6, 2003; 42(3): 477 - 482. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, H. A. Rajasinghe, J. M. Chen, A. D. Weinberg, P. Sinha, D. M. Mancini, Y. Naka, M. C. Oz, C. R. Smith, E. A. Rose, et al. Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy Ann. Thorac. Surg., August 1, 2001; 72(2): 440 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. John, H. A. Rajasinghe, S. Itescu, S. Suratwalla, K. Lietz, A. D. Weinberg, A. Kocher, D. M. Mancini, R. E. Drusin, M. C. Oz, et al. Factors affecting long-term survival (>10 years) after cardiac transplantation in the cyclosporine era J. Am. Coll. Cardiol., January 1, 2001; 37(1): 189 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. KASISKE and D. KLINGER Cigarette Smoking in Renal Transplant Recipients J. Am. Soc. Nephrol., April 1, 2000; 11(4): 753 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lindelow, C.-H. Bergh, C. Lamm, B. Andersson, and F. Waagstein Graft coronary artery disease is strongly related to the aetiology of heart failure and cellular rejections Eur. Heart J., September 2, 1999; 20(18): 1326 - 1334. [Abstract] [PDF] |
||||
![]() |
M. Schwaiblmair, W. v. Scheidt, P. Uberfuhr, B. Reichart, and C. Vogelmeier Lung Function and Cardiopulmonary Exercise Performance After Heart Transplantation: Influence of Cardiac Allograft Vasculopathy Chest, August 1, 1999; 116(2): 332 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lemstrom, P. Koskinen, L. Krogerus, M. Daemen, C. Bruggeman, and P. Hayry Cytomegalovirus Antigen Expression, Endothelial Cell Proliferation, and Intimal Thickening in Rat Cardiac Allografts After Cytomegalovirus Infection Circulation, November 1, 1995; 92(9): 2594 - 2604. [Abstract] [Full Text] |
||||
![]() |
J. Botas, F. J. Pinto, A. Chenzbraun, D. Liang, J. S. Schroeder, S. N. Oesterle, E. L. Alderman, R. L. Popp, and A. C. Yeung Influence of Preexistent Donor Coronary Artery Disease on the Progression of Transplant Vasculopathy : An Intravascular Ultrasound Study Circulation, September 1, 1995; 92(5): 1126 - 1132. [Abstract] [Full Text] |
||||
![]() |
W. M. DeCampli, H. Luikart, S. Hunt, and E. B. Stinson Characteristics of patients surviving more than ten years aftercardiac transplantation J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1103 - 1115. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |